Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,088,948
+$3,900,297 QoQ
Shares Held
24,261
+1594.2% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#235
of 772 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (28.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in NBIX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,088,948 | 24,261 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $188,651 | 1,432 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $54,037 | 381 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,662,086 | 40,334 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,711 | 125 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $14,378 | 130 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $72,891 | 534 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $90,102 | 782 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $107,657 | 782 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,930 | 43 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,665 | 43 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,174 | 46 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,489 | 37 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,656 | 46 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $5,494 | 46 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $4,885 | 46 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,606 | 37 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $3,468 | 37 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||